Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 14, 2019
[Radiotherapy and PD-L1 Expression]
Hiro Sato, Noriyuki Okonogi, Yuya Yoshimoto, et al.
Anticancer Research
|
July 5, 2022
Comparative Analysis of the Antitumor Immune Profiles of Paired Radiotherapy-naive and Radiotherapy-treated Cervical Cancer Tissues
Ayaka Imamura, Takahiro Oike, Hiro Sato, et al.
Bioorganic & Medicinal Chemistry
|
November 23, 2019
Discovery of metyltetraprole: Identification of tetrazolinone pharmacophore to overcome QoI resistance
Yuichi Matsuzaki, Yuya Yoshimoto, Sadayuki Arimori, et al.
Clinical Case Reports
|
January 25, 2021
Granulocyte-colony stimulating factor-producing uterine cervical cancer treated with chemoradiotherapy: A case report with mutation analysis and literature review
Shintaro Shiba, Takahiro Oike, Ken Ando, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association
|
June 21, 2025
Prognostic factors influencing the occurrence of drug-induced renal dysfunction during continuous local antibiotic perfusion therapy
Yuki Fujihara, Kazuki Uchibori, Yuya Yoshimoto, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2002
Vacuolar-type H(+)-ATPase inhibitory activity of synthetic analogues of the concanamycins: is the hydrogen bond network involving the lactone carbonyl, the hemiacetal hydroxy group, and the C-19 hydroxy group essential for the biological activity of the concanamycins?
Yuya Yoshimoto, Takaaki Jyojima, Tsuyoshi Arita, et al.
Heliyon
|
June 9, 2023
Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer
Takahiro Oike, Naoto Osu, Yuya Yoshimoto, et al.
Japanese Journal of Radiology
|
December 3, 2021
High tumor mutational burden predicts worse prognosis for cervical cancer treated with radiotherapy
Norichika Ota, Yuya Yoshimoto, Narisa Dewi Maulany Darwis, et al.
Journal of Radiation Research
|
June 28, 2018
High linear energy transfer carbon-ion irradiation increases the release of the immune mediator high mobility group box 1 from human cancer cells
Masahiro Onishi, Noriyuki Okonogi, Takahiro Oike, et al.
Anticancer Research
|
July 28, 2004
A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells
Manabu Kawada, Yuya Yoshimoto, Kazuhisa Minamiguchi, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 14, 2019
[Radiotherapy and PD-L1 Expression]
Hiro Sato, Noriyuki Okonogi, Yuya Yoshimoto, et al.
Anticancer Research
|
July 5, 2022
Comparative Analysis of the Antitumor Immune Profiles of Paired Radiotherapy-naive and Radiotherapy-treated Cervical Cancer Tissues
Ayaka Imamura, Takahiro Oike, Hiro Sato, et al.
Bioorganic & Medicinal Chemistry
|
November 23, 2019
Discovery of metyltetraprole: Identification of tetrazolinone pharmacophore to overcome QoI resistance
Yuichi Matsuzaki, Yuya Yoshimoto, Sadayuki Arimori, et al.
Clinical Case Reports
|
January 25, 2021
Granulocyte-colony stimulating factor-producing uterine cervical cancer treated with chemoradiotherapy: A case report with mutation analysis and literature review
Shintaro Shiba, Takahiro Oike, Ken Ando, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association
|
June 21, 2025
Prognostic factors influencing the occurrence of drug-induced renal dysfunction during continuous local antibiotic perfusion therapy
Yuki Fujihara, Kazuki Uchibori, Yuya Yoshimoto, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2002
Vacuolar-type H(+)-ATPase inhibitory activity of synthetic analogues of the concanamycins: is the hydrogen bond network involving the lactone carbonyl, the hemiacetal hydroxy group, and the C-19 hydroxy group essential for the biological activity of the concanamycins?
Yuya Yoshimoto, Takaaki Jyojima, Tsuyoshi Arita, et al.
Heliyon
|
June 9, 2023
Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer
Takahiro Oike, Naoto Osu, Yuya Yoshimoto, et al.
Japanese Journal of Radiology
|
December 3, 2021
High tumor mutational burden predicts worse prognosis for cervical cancer treated with radiotherapy
Norichika Ota, Yuya Yoshimoto, Narisa Dewi Maulany Darwis, et al.
Journal of Radiation Research
|
June 28, 2018
High linear energy transfer carbon-ion irradiation increases the release of the immune mediator high mobility group box 1 from human cancer cells
Masahiro Onishi, Noriyuki Okonogi, Takahiro Oike, et al.
Anticancer Research
|
July 28, 2004
A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells
Manabu Kawada, Yuya Yoshimoto, Kazuhisa Minamiguchi, et al.
Page
of 6